S-Gem

S-Gem is a thioredoxin reductase (TrxR) -activated prodrug of Gemcitabine designed for targeted cytotoxicity. It demonstrates reduced off-target toxicity compared to the parent compound, making it a useful research tool for studying redox biology and prodrug strategies in cancer models, both in vitro and in vivo.